Biological variation of interleukin-1β, interleukin-8 and tumor necrosis factor-α in serum of healthy individuals

被引:25
作者
González, C
Cava, F
Ayllón, A
Guevara, P
Navajo, JA
González-Buitrago, JM [1 ]
机构
[1] Univ Hosp, Serv Bioquim, E-37007 Salamanca, Spain
[2] Univ Salamanca, Dept Bioquim & Biol Mol, E-37007 Salamanca, Spain
[3] Fdn Hosp Alcorcon, Lab Serv, Madrid, Spain
[4] DPC Dipesa, Madrid, Spain
关键词
biological variation; critical differences; index of individuality; interleukin-1; beta; interleukin-8; tumor necrosis factor-alpha;
D O I
10.1515/CCLM.2001.139
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Components of biological variation can be used to assess the usefulness of reference values, to evaluate the significance of changes in serial results from an individual and to define objective analytical goals. The aim of the study was to assess, in 15 healthy subjects studied at regular monthly intervals over a period of 6 consecutive months, the biological variation of interleukin-1 beta (IL-1 beta), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-alpha). Biological variation data (within-subject and between-subject coefficient of variation (CV)) were determined using a simple nested analysis of variance. Derived parameters (index of individuality, reliability coefficient and critical diferences) were calculated from within-subject and between-subject CV. The mean and standard deviation (SD), within-subject CV, between-subject CV, index of individuality and reliability coefficient were as follows: for IL-1 beta, 0.67 (0.32) pg/ml, 30%, 36%, 0.85, and 0.76; for IL-8, 3.68 (1.45) pg/ml, 24%, 31%, 0.85 and 0.75; and for TNF-alpha, 3.14 (1.87) pg/ml, 43%, 29%, 1.56 and 0.50, respectively. We conclude that between-subject variation and within-subject variation are quite similar for IL-1 beta and IL-8 and are relatively high for the three cytokines studied. Index of individuality is less than 1.4 for IL-1 beta and IL-8, and thus reference intervals based on population studies are of limited value. On the contrary, the index of individuality for TNF-alpha is greater than 1.4 and reference values can be used for diagnosis. Quality goals for imprecision are easily achieved for the three cytokines with current methodology.
引用
收藏
页码:836 / 841
页数:6
相关论文
共 22 条
[1]   Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection [J].
Aziz, N ;
Nishanian, P ;
Taylor, JMG ;
Mitsuyasu, RT ;
Jacobson, JM ;
Dezube, BJ ;
Lederman, MM ;
Detels, R ;
Fahey, JL .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :843-848
[2]   The clinical usefulness of the measurement of cytokines [J].
Bienvenu, J ;
Monneret, G ;
Fabien, N ;
Revillard, JP .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (04) :267-285
[3]   Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2r) in serum of healthy individuals [J].
Cava, F ;
González, C ;
Pascual, MJ ;
Navajo, JA ;
González-Buitrago, JM .
CYTOKINE, 2000, 12 (09) :1423-1425
[4]   The distribution of the largest of a set of estimated variances as a fraction of their total [J].
Cochran, WG .
ANNALS OF EUGENICS, 1941, 11 :47-52
[5]   Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation [J].
Fahey, JL ;
Aziz, N ;
Spritzler, J ;
Plaeger, S ;
Nishanian, P ;
Lathey, JL ;
Seigel, J ;
Landay, AL ;
Kilarui, R ;
Schmitz, JL ;
White, C ;
Wara, DW ;
Akridge, R ;
Cutili, J ;
Douglas, SD ;
Reuben, J ;
Shearer, WT ;
Nokta, M ;
Polland, R ;
Schooley, R ;
Asthana, D ;
Mizrachi, Y ;
Waxdal, M .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (04) :540-548
[6]   DESIRABLE PERFORMANCE STANDARDS FOR CLINICAL-CHEMISTRY TESTS [J].
FRASER, CG .
ADVANCES IN CLINICAL CHEMISTRY, 1983, 23 :299-339
[7]  
FRASER CG, 1989, CRIT REV CL LAB SCI, V27, P409
[8]  
FRASER CG, 1992, EUR J CLIN CHEM CLIN, V30, P311
[9]   Proposals for setting generally applicable quality goals solely based on biology [J].
Fraser, CG ;
Petersen, PH ;
Libeer, JC ;
Ricos, C .
ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 :8-12
[10]  
FRASER CG, 1992, ARCH PATHOL LAB MED, V116, P916